Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer
2012 · Journal of Clinical Oncology · 161 citations
https://doi.org/10.1200/jco.2011.36.7771
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
33
Papers
706
Citations
11
h-index
12
i10-index
J. G. M. Segalla is an academic researcher from Hospital Amaral Carvalho. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Colorectal Cancer Treatments and Studies & Breast Cancer Treatment Studies. The author has an h-index of 11, co-authored 29 publications.
https://doi.org/10.1200/jco.2011.36.7771
https://doi.org/10.1200/jco.19.00904
Click to start Chat